“CD19 CAR-T Cell Treatment in Systemic Lupus Erythematosus: Insights into B Cell Role and Pathogenesis”

https://pubmed.ncbi.nlm.nih.gov/38114423

The review discusses how CD19 CAR-T cell treatment in systemic lupus erythematosus (SLE) provides insights into the role of B cells in SLE pathogenesis, including understanding aberrant B cell activation, the effects of B cell depletion on autoantibody production, and the safety of deep B cell depletion in autoimmune disease.